Back Villumsen, M, Schelde, AB Jimenez-Solem, E (July 2021) 'GLP-1 based therapies and disease course of inflammatory bowel disease', eClinical Medicine, 37/100979
The discrepancy was reduced when restricting to the 195 participants with both survey and EHR data, but remained significant (self-report = 14.14% versus 8.43% in EHR, P = 1.1 10 9 paired t -test
That's our job as responsible scientists. It also remains unknown whether there will be any new side effects that pop up if people remain on these drugs for 30, 40, or 50-plus years
Innovations in peptide discovery are now exploring targeted compounds designed to support sleep onset and quality through non-sedative physiological pathways
Glycemic Control Pendulum GLP-1 Probiotic contains a unique strain known to aid individuals with Type 2 Diabetes in managing blood sugar levels